Free News Archives
Latest Issue of OR Manager
March 2025

Costs drop, access expands for GLP-1 weight loss drugs

Editor's Note Access to GLP-1 medications is improving as manufacturers, insurers, and policymakers address high demand, costs, and coverage challenges, Becker’s Hospital Review reported December 13. As detailed in the article, Eli Lilly’s partnership with telehealth company Ro now allows patients to obtain Zepbound prescriptions online and receive shipments directly…

Read More

By: Matt Danford
December 13, 2024
Share

Q&A: Perioperative immunotherapy advances for early-stage NSCLC

Editor's Note Perioperative immunotherapy is reshaping treatment strategies for early-stage non-small cell lung cancer (NSCLC) without actionable mutations, according to Dr. Roy S. Herbst of Yale Cancer Center. In a recent interview with OncLive, the oncology expert highlighted the promise of neoadjuvant and adjuvant therapies to improve outcomes for these…

Read More

By: Matt Danford
December 13, 2024
Share

Proposals close December 16: Present at the 2025 OR Manager Conference

Editor's Note The 2025 OR Manager Conference Program Committee is seeking presentation proposals from passionate perioperative leaders and experts to share their experience October 28-30, 2025, in Anaheim, California.  The OR Manager Conference is the only conference providing education specific to the needs of perioperative leaders in all facility types…

Read More

By: Lindsay Botts, MA
December 12, 2024
Share

ASA recommendations target postoperative delirium in older patients

Editor's Note Efforts to reduce the risk of postoperative delirium in older patients should focus on preoperative evaluation, anesthesia choices, and medication management, according to the American Society of Anesthesiologists (ASA). Designed specifically for treating adults aged 65 and older undergoing inpatient surgery, these new, evidence-based recommendations are presented in…

Read More

By: Matt Danford
December 12, 2024
Share

Infusion pump problems prompt early FDA safety warning

Editor's Note Risk of delayed therapy and death related to Ivenix large-volume infusion pumps is prompting supplier Fresenius Kabi USA to pull a subset of the devices from the market, according to an early alert from The US Food and Drug Administration (FDA). Issued December 11, the early alert is…

Read More

By: Matt Danford
December 12, 2024
Share

OR Business Management Conference will offer new ASC content in 2025

Editor's Note We’ve raised the bar—for the first time in 13 years, the OR Business Management Conference will feature a dedicated lineup of content specifically for ambulatory surgery center (ASC) leaders. Join an intimate gathering of ASC administrators, directors, and C-suite executives to dig deeper into financial, operational, and strategic…

Read More

By: Tarsilla Moura
December 11, 2024
Share

Video details healthcare cybersecurity challenges

Editor's Note "Why is healthcare cybersecurity so bad?" This is the central question explored in a December 4 video from STAT health tech reporter Brittany Trang, who also wrote an article on the subject earlier this year. Brought into sharp focus by data exposures related to the recent attack on…

Read More

By: Matt Danford
December 10, 2024
Share

Study: Virtual reality videos ease fear, anxiety in cardiac surgery patients

Editor's Note Using virtual reality glasses (VR-G) to watch immersive 360-degree nature videos significantly reduces preoperative surgical fear in patients undergoing open-heart surgery, according to a randomized controlled study published November 29 in the Journal of Perianesthesia Nursing. However, anxiety levels were not markedly affected, suggesting targeted efficacy in fear…

Read More

By: Matt Danford
December 10, 2024
Share

Study: Antibiotic de-escalation reduces adverse outcomes in patients with sepsis

Editor's Note A study analyzing data from 124,577 suspected sepsis cases across 236 US hospitals found that antibiotic de-escalation—switching to narrower-spectrum antibiotics or stopping broad-spectrum antibiotics—occurred in less than 30% of cases but was associated with improved patient outcomes, according to December 6 report from the Center for Infectious Disease…

Read More

By: Matt Danford
December 10, 2024
Share

Demand for skin removal surgeries surges amid weight loss drug boom

Editor's Note Demand for skin removal surgeries has risen sharply in the US, fueled by the popularity of GLP-1 weight loss drugs like Ozempic and Wegovy, CNN reported December 9. The trend reflects a growing need for procedures that address loose, sagging skin following significant weight loss, particularly as the…

Read More

By: Matt Danford
December 10, 2024
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat